Home/Filings/4/A/0001209191-23-005336
4/A//SEC Filing

Carter Martha J. 4/A

Accession 0001209191-23-005336

CIK 0001322505other

Filed

Jan 26, 7:00 PM ET

Accepted

Jan 27, 5:27 PM ET

Size

5.6 KB

Accession

0001209191-23-005336

Insider Transaction Report

Form 4/AAmended
Period: 2023-01-19
Carter Martha J.
Chief Regulatory Officer
Transactions
  • Award

    Common Stock

    2023-01-19+55,00069,506 total
Footnotes (2)
  • [F1]Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest as to 25% of the shares on January 19, 2024, 6.25% of the shares every three months thereafter beginning on April 19, 2024 and ending on January 19, 2025, and 12.5% of the shares every three months thereafter beginning on April 19, 2025 and ending on January 19, 2026.
  • [F2]Represents 3,656 shares of common stock and 65,850 restricted stock units.

Issuer

ALBIREO PHARMA, INC.

CIK 0001322505

Entity typeother

Related Parties

1
  • filerCIK 0001213040

Filing Metadata

Form type
4/A
Filed
Jan 26, 7:00 PM ET
Accepted
Jan 27, 5:27 PM ET
Size
5.6 KB